National Reference Centre for Staphylococci and Enterococci, Division of Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, Wernigerode, Saxony-Anhalt, Germany.
National Reference Centre for Staphylococci and Enterococci, Division of Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, Wernigerode, Saxony-Anhalt, Germany.
Int J Antimicrob Agents. 2018 Dec;52(6):819-827. doi: 10.1016/j.ijantimicag.2018.09.009. Epub 2018 Sep 17.
The number of linezolid-resistant Enterococcus spp. isolates received by the National Reference Centre for Staphylococci and Enterococci in Germany has been increasing since 2011. Although the majority are E. faecium, clinical linezolid-resistant E. faecalis have also been isolated. With respect to the newly discovered linezolid resistance protein OptrA, the authors conducted a retrospective polymerase chain reaction screening of 698 linezolid-resistant enterococcus clinical isolates. That yielded 43 optrA-positive strains, of which a subset was analysed by whole-genome sequencing in order to infer linezolid resistance-associated mechanisms and phylogenetic relatedness, and to disclose optrA genetic environments. Multiple optrA variants were detected. The originally described variant from China (optrA) was the only variant shared between the two Enterococcus spp.; however, distinct optrA loci were detected for E. faecium and E. faecalis. Generally, optrA localized to a plethora of genetic backgrounds that differed even for identical optrA variants. This suggests transmission of a mobile genetic element harbouring the resistance locus. Additionally, identical optrA variants detected on presumably identical plasmids, that were present in unrelated strains, indicates dissemination of the entire optrA-containing plasmid. In accordance, in vitro conjugation experiments verified transfer of optrA plasmids between enterococci of the same and of different species. In conclusion, multiple optrA variants located on distinct plasmids and mobile genetic elements with the potential for conjugative transfer are supposedly causative for the emergence of optrA-positive enterococci. Hence, rapid dissemination of the resistance determinant under selective pressure imposed by extensive use of last-resort antibiotics in clinical settings could be expected.
自 2011 年以来,德国国家葡萄球菌和肠球菌参考中心收到的耐利奈唑胺肠球菌分离株数量不断增加。虽然大多数是屎肠球菌,但也分离到了临床耐利奈唑胺屎肠球菌。关于新发现的利奈唑胺耐药蛋白 OptrA,作者对 698 株耐利奈唑胺肠球菌临床分离株进行了回顾性聚合酶链反应筛选。这产生了 43 株 optrA 阳性菌株,其中一部分通过全基因组测序进行了分析,以推断利奈唑胺耐药相关机制和系统发育相关性,并揭示 optrA 遗传环境。检测到多种 optrA 变体。最初描述的来自中国的变体(optrA)是两种肠球菌之间唯一共享的变体;然而,粪肠球菌和屎肠球菌的 optrA 基因座不同。通常,optrA 定位于多种遗传背景,即使对于相同的 optrA 变体也是如此。这表明携带耐药基因座的可移动遗传元件的传播。此外,在假定相同的质粒上检测到相同的 optrA 变体,而这些质粒存在于无关的菌株中,表明整个含有 optrA 的质粒的传播。因此,体外接合实验证实了相同和不同种属肠球菌之间 optrA 质粒的转移。总之,推测位于不同质粒和具有潜在可接合转移能力的移动遗传元件上的多种 optrA 变体是 optrA 阳性肠球菌出现的原因。因此,在临床环境中广泛使用最后手段抗生素施加选择压力下,预计耐药决定因素会迅速传播。